Navigation Links
Accentia Biopharmaceuticals Announces Favorable Interim Blinded,Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial,for Chronic Sinusitis

tients who reported complete resolution of one cardinal symptom there was an average improvement in endoscopy scores of 12%. In patients who reported resolution of both cardinal symptoms there was an average improvement in endoscopy scores of 23%."

The clinical trial has reached approximately 80% enrollment and the Company believes it will finish enrollment of the 300 patients required for randomization during the summer. Unblinded top-line results for all patients are expected to be available before the end of the year.

Members of the investment community, the media, and other interested parties can access the PowerPoint presentation and an audio webcast by visiting Accentia's homepage at www.accentia.net, or for audio only, http://www.wsw.com/webcast/jeff18/abpi. The PowerPoint presentation and audio will be available and archived on Accentia's website for 90 days.

About Accentia Biopharmaceuticals, Inc.

Accentia Biopharmaceuticals, Inc. and its subsidiaries (collectively referred to as the "Company" or "Accentia") is a vertically integrated biopharmaceutical company focused on the development and commercialization of drug candidates that are in late-stage clinical development and typically are based on active pharmaceutical ingredients that have been previously approved by the FDA for other indications. Usually these drug candidates can access the accelerated 505(b)(2) regulatory approval pathway, which is generally less time-consuming and less expensive than the typical 505(b)(1) pathway that must be used for new chemical entities. The Company's lead product candidate is SinuNase(TM), a novel application and formulation of a known therapeutic to treat chronic rhinosinusitis. SinuNase has been granted Fast Track status by the FDA and it is currently in a pivotal Phase 3 clinical trial. During this fiscal year, the Company also plans to file an Investigative New Drug (IND) for a pivotal Phase 3 clinical trial of Revimmune, to treat nume
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:7/14/2014)... July 14, 2014 CVS/pharmacy ® ... PLATINUM, a premium brand of 100% preservative-free vitamins ... growing family of exclusive CVS/pharmacy store brand products. ... with various benefits, including popular options such as ... women. The radiance PLATINUM line also has more premium options ...
(Date:7/14/2014)... , July 14, 2014 The legalization of ... – as well as a new economic driver – ... to sort out the right response to the will ... intoxicant. At a National Press Club ... a.m., two leading experts in the area of marijuana ...
(Date:7/14/2014)... N.Y. , July 14, 2014 We ... Surgery Center ("OACM") and the Ellicott City Ambulatory Surgery ... of Ellicott City Maryland . ... between Merritt Healthcare and 14 leading Orthopaedics, Sports Medicine, ... Facility will also accommodate the specialties of general surgery ...
Breaking Medicine Technology:CVS/pharmacy Launches Exclusive radiance PLATINUM Line of Preservative-Free Vitamins and Supplements 2CVS/pharmacy Launches Exclusive radiance PLATINUM Line of Preservative-Free Vitamins and Supplements 3NPC Newsmaker Program: Interpreting smoke signals from the marijuana skirmish line 2
(Date:7/14/2014)... Documented Legacy , a mobile personal ... of its first military memoir about a World War II ... October 1943 and 19 months as a prisoner of war ... the American dream. , From the Top Turret: A ... (Amazon) is a true life story of Gerard Caporaso’s ...
(Date:7/14/2014)... 2014 The Retina Group of ... Hauppauge, NY, has announced the availability of Ozurdex® ... diabetic macular edema (DME) patients. Ozurdex, a corticosteroid ... indication for use in diabetic macular edema. Ozurdex ... for treatment of retinal vascular occlusions and and ...
(Date:7/14/2014)... 14, 2014 According to a recent ... researchers have discovered a connection between women with high ... of infertility. Although doctors have theorized about the role ... first study to provide scientific support. , “Stress, if ... said Dr. Larry Barmat, an OB/GYN who specializes in ...
(Date:7/14/2014)... 2014 Last month Bromell Agency officially ... The webpage features more detailed information on how clients ... RVs, ATVs, and boats in the state of Louisiana. ... feature to the website in order to better educate ... the purpose of the website, which is to display ...
(Date:7/14/2014)... 14, 2014 There’s an old adage that ... The Lash Palette say the products offered in their ... , “You can reserve The Lash Palette for $40,” said ... Store . , Paris explained that the first 1,000 have ... 21. , She went on to point out that her ...
Breaking Medicine News(10 mins):Health News:Mount Laurel-based Documented Legacy to Release Military Memoir of World War II Air Force Vet Who Survived Black Thursday Crash 2Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 2Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 3Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:The Lash Palette Preorder Event Has Officially Begun 2
... , , WASHINGTON , Feb. 8 ... showed he has what it takes to win big. Not only does ... own Milk Mustache. The 13th annual winning football Milk Mustache ad runs ...   http://www.newscom.com/cgi-bin/prnh/20100208/AQ51302 ) , The famed running back is the latest superstar ...
... Nev. , Feb. 8 The Whittemore Peterson ... Donnica Moore , a distinguished women,s health expert, as its ... in its efforts to help raise awareness and funding for ... Fatigue Syndrome.   , "We are pleased to have a ...
... ... Health, a joint venture between Humility of Mary Health Partners (HMHP) , NEO ... Ohio,s first and only radiation oncology center with Elekta Volumetric Modulated Arc Therapy (VMAT), ... ...
... , , NORTHBROOK, Ill. , ... a global leader in environmental evaluation and certification, announces ... materials used in consumer and manufactured goods.  These standards ... scientific assessment and broad stakeholder collaboration.   , This ...
... the use of computed tomography (CT scans) in children ... of scans, according to a new study in ... link only) http://www.cmaj.ca/embargo/cmaj091421.pdf . More than 650,000 ... consciousness, amnesia, disorientation and/or vomiting are seen each year ...
... JRS Medical ... that the Company is donating a percentage of all of their January & February 2010 ... employees also are raising funds locally for victims of the tragic earthquake. , ... (PRWEB) February 8, 2010 -- JRS Medical ...
Cached Medicine News:Health News:Reggie Bush Takes Down Reggie Wayne in Battle for the Milk Mustache! 2Health News:Whittemore Peterson Institute Announces Renowned Health Expert as New Spokesperson 2Health News:Partners for Urology Health First in Ohio with New Radiation Therapy Technology 2Health News:Partners for Urology Health First in Ohio with New Radiation Therapy Technology 3Health News:UL Environment to Develop Sustainability Standards For Plastic 2Health News:New CATCH rule to determine need for CT scans in children with minor head injury 2Health News:JRS Medical Raises Funds for Devastated Victims in Haiti 2Health News:JRS Medical Raises Funds for Devastated Victims in Haiti 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: